- Investing Ideas
- Chinese Pharmaceuticals & Biotech Healthy high growth potential
Chinese Pharmaceuticals & Biotech Healthy high growth potential
Results
6
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
6 companies
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥27.0b
A commercial-stage biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of oncology and hematologic disorders.
688192
CN¥58.79
7D
10.9%
1Y
-27.3%
PharmaResources (Shanghai)
Market Cap: CN¥6.8b
Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.
301230
CN¥39.60
7D
45.0%
1Y
37.6%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥9.7b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥26.03
7D
11.1%
1Y
-25.9%
AcrobiosystemsLtd
Market Cap: CN¥13.8b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥82.20
7D
52.3%
1Y
43.9%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥8.2b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥15.60
7D
15.7%
1Y
-1.1%
Inner Mongolia Furui Medical Science
Market Cap: CN¥11.8b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥44.52
7D
-4.6%
1Y
-8.8%